Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 250 | $119,261,668 |
Sells | 4 | $198,660,583 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 26,450 | 6.4215 | 169,849 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 3,118 | 6.4215 | 20,022 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 7,815 | 6.3537 | 49,654 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 06 Jun 2022 | Purchase | 921 | 6.3537 | 5,852 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 2,364 | 5.8202 | 13,759 | I |
06 Jun 2022 17:07 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 02 Jun 2022 | Purchase | 279 | 5.8202 | 1,624 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 19,789 | 5.7415 | 113,619 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 2,334 | 5.7415 | 13,401 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 1,521 | 5.93 | 9,020 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 24 May 2022 | Purchase | 179 | 5.93 | 1,061 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 7,010 | 5.9874 | 41,972 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 23 May 2022 | Purchase | 827 | 5.9874 | 4,952 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,772 | 5.8421 | 45,405 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 946 | 5.8421 | 5,527 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 7,248 | 5.8409 | 42,335 | I |
24 May 2022 18:39 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 20 May 2022 | Purchase | 883 | 5.8409 | 5,158 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 30,003 | 6 | 180,018 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 3,654 | 6 | 21,924 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 692 | 5.918 | 4,095 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 18 May 2022 | Purchase | 84 | 5.918 | 497 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 17 May 2022 | Purchase | 16,501 | 6.1301 | 101,153 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 17 May 2022 | Purchase | 2,010 | 6.1301 | 12,322 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 16 May 2022 | Purchase | 16,937 | 5.8259 | 98,673 | I |
18 May 2022 17:38 | TRDA | Entrada Therapeutics Inc | BAKER BROS. ADVISORS LP | 10% | 16 May 2022 | Purchase | 2,063 | 5.8259 | 12,019 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 61,134 | 0.6928 | 42,354 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 5,041 | 0.6928 | 3,492 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 93,091 | 0.6924 | 64,456 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 17 Aug 2023 | Purchase | 7,676 | 0.6924 | 5,315 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 4,434 | 0.6828 | 3,028 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 366 | 0.6828 | 250 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 207,676 | 0.6805 | 141,324 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 16 Aug 2023 | Purchase | 17,124 | 0.6805 | 11,653 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 4,342 | 0.665 | 2,887 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 358 | 0.665 | 238 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 1,740,581 | 0.6308 | 1,097,958 | I |
17 Aug 2023 17:08 | NLTX | Neoleukin Therapeutics Inc | BAKER BROS. ADVISORS LP | Director , 10% | 15 Aug 2023 | Purchase | 143,519 | 0.6308 | 90,532 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 3,960 | 229.8647 | 910,264 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 316 | 229.8647 | 72,637 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 176 | 228.7893 | 40,267 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 2,204 | 228.7893 | 504,252 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 11,602 | 227.857 | 2,643,597 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 925 | 227.857 | 210,768 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 1,343 | 226.971 | 304,822 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 107 | 226.971 | 24,286 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 5,594 | 224.9117 | 1,258,156 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 363 | 223.9374 | 81,289 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 446 | 224.9117 | 100,311 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 29 | 223.9374 | 6,494 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 9,262 | 222.676 | 2,062,425 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 738 | 222.676 | 164,335 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 4,532 | 221.7787 | 1,005,101 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 361 | 221.7787 | 80,062 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 4,518 | 219.8652 | 993,351 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 360 | 219.8652 | 79,151 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 29,738 | 218.4583 | 6,496,513 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 2,373 | 218.4583 | 518,402 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 10,894 | 217.5152 | 2,369,611 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 10,264 | 216.6994 | 2,224,203 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 869 | 217.5152 | 189,021 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 818 | 216.6994 | 177,260 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 3,857 | 221.2418 | 853,330 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 308 | 221.2418 | 68,142 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 4,408 | 220.6546 | 972,645 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 352 | 220.6546 | 77,670 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 1,195 | 219.241 | 261,993 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15,005 | 219.241 | 3,289,711 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 2,873 | 217.9078 | 626,049 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 229 | 217.9078 | 49,901 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 185 | 217.9 | 40,312 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 217.9 | 3,268 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 1,769 | 216.6683 | 383,286 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 141 | 216.6683 | 30,550 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 668 | 214.7223 | 143,434 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 53 | 214.7223 | 11,380 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 515 | 213.7994 | 110,107 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 41 | 213.7994 | 8,766 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 185 | 213.625 | 39,521 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 15 | 213.625 | 3,204 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 648 | 212.0414 | 137,403 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 93 | 209.765 | 19,508 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 52 | 212.0414 | 11,026 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 370 | 208.6913 | 77,216 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 209.765 | 1,468 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 30 | 208.6913 | 6,261 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 648 | 206.9321 | 134,092 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 52 | 206.9321 | 10,760 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 708 | 205.6 | 145,565 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 56 | 205.6 | 11,514 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 93 | 205.32 | 19,095 | I |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 7 | 205.32 | 1,437 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 7,917 | 190.1361 | 1,505,308 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 655 | 190.1361 | 124,539 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 15,620 | 188.7029 | 2,947,539 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 1,291 | 188.7029 | 243,615 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 13,505 | 188.4649 | 2,545,218 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 1,117 | 188.4649 | 210,515 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 13,011 | 188.3232 | 2,450,273 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 1,076 | 188.3232 | 202,636 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 4,712 | 187.2707 | 882,420 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 388 | 187.2707 | 72,661 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)